Recognizing and Confirming Potential ATTR in Your Patients

Target Audience
This activity is designed to meet the educational needs of physicians, allied health practitioners, and students interested in complex cardiovascular and thoracic conditions and those who care for patients with ATTR.

Program Overview
This activity will cover early diagnosis and intervention for transthyretin amyloidosis (ATTR), which is critical, yet does not occur, typically as a consequence of the rarity and heterogeneity of the disease and limited awareness on the part of clinicians. Therapeutic options are limited, but there are new and emerging agents and emerging indications with which clinicians may not be familiar. Access to specialized care centers is limited for many patients, leading to suboptimal management and disease monitoring. This education fills a significant need for healthcare team education to ensure all patients benefit from best practices in recognizing, diagnosing, and managing amyloidosis.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Identify common diagnostic issues for patients with ATTR
Recognize ATTR genotypes and phenotypes, including typical symptomatology
Discuss multidisciplinary strategies for confirming ATTR diagnosis